Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancerRavi A. Madan, James L. Gulley, Marijo Bilušić et al.|Journal for ImmunoTherapy of Cancer|2021Cited by 31
Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancerRavi A. Madan, William L. Dahut, Fatima Karzai et al.|British Journal of Urology|2020Cited by 13